APA (7th ed.) Citation

Ismail, T., Alzneika, S., Riguene, E., Al-maraghi, S., Alabdulrazzak, A., Al-Khal, N., . . . Nomikos, M. (2024). BRCA1 and Its Vulnerable C-Terminal BRCT Domain: Structure, Function, Genetic Mutations and Links to Diagnosis and Treatment of Breast and Ovarian Cancer. Pharmaceuticals (14248247), 17(3), 333. https://doi.org/10.3390/ph17030333

Chicago Style (17th ed.) Citation

Ismail, Tala, et al. "BRCA1 and Its Vulnerable C-Terminal BRCT Domain: Structure, Function, Genetic Mutations and Links to Diagnosis and Treatment of Breast and Ovarian Cancer." Pharmaceuticals (14248247) 17, no. 3 (2024): 333. https://doi.org/10.3390/ph17030333.

MLA (9th ed.) Citation

Ismail, Tala, et al. "BRCA1 and Its Vulnerable C-Terminal BRCT Domain: Structure, Function, Genetic Mutations and Links to Diagnosis and Treatment of Breast and Ovarian Cancer." Pharmaceuticals (14248247), vol. 17, no. 3, 2024, p. 333, https://doi.org/10.3390/ph17030333.